scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019376877 |
P356 | DOI | 10.1186/1477-7827-7-85 |
P932 | PMC publication ID | 2733305 |
P698 | PubMed publication ID | 19698156 |
P5875 | ResearchGate publication ID | 26758566 |
P2093 | author name string | Eliezer Shalev | |
Shlomit Goldman | |||
Etty Daniel-Spiegel | |||
Michal Lavee | |||
P2860 | cites work | The effect of serum from women with preeclampsia on JAR (trophoblast-like) cell line | Q40393008 |
Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery | Q44555376 | ||
The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia | Q45029086 | ||
The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. | Q47674713 | ||
Vascular endothelial growth factor induces endothelin-1 production via matrix metalloproteinase-2 rather than endothelin-converting enzyme-1. | Q53571836 | ||
MMP-2 Levels are Elevated in the Plasma of Women Who Subsequently Develop Preeclampsia | Q58036004 | ||
Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension | Q60717340 | ||
What's in a name? Problems with the classification of hypertension in pregnancy | Q73831356 | ||
Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia | Q74226798 | ||
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension | Q81589874 | ||
Matrix metalloproteinases: effectors of development and normal physiology | Q28679038 | ||
Preeclamptic decidual microvascular endothelial cells express lower levels of matrix metalloproteinase-1 than normals. | Q30700181 | ||
Matrix metalloproteinases: biologic activity and clinical implications | Q33849967 | ||
Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. | Q34307809 | ||
Human endothelial gelatinases and angiogenesis | Q34317873 | ||
The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature | Q35002391 | ||
Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
The role of the matrix metalloproteinases in human endometrial and ovarian cycles | Q35575331 | ||
Membrane associated proteases and their inhibitors in tumour angiogenesis | Q35587684 | ||
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 85 | |
P577 | publication date | 2009-08-23 | |
P1433 | published in | Reproductive Biology and Endocrinology | Q15767218 |
P1476 | title | Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia | |
P478 | volume | 7 |
Q93051696 | A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia |
Q34340129 | A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). |
Q42269581 | Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia |
Q34114194 | Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes |
Q41949055 | Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia |
Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
Q36009930 | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease |
Q46305713 | Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia |
Q37993746 | Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications |
Q36910638 | Matrix metalloproteinases as drug targets in preeclampsia |
Q37700240 | Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia |
Search more.